Nevro Corp.
USPTO PatentsView assignee record - 152 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Nevro ranks #2,564 of 49,997 tracked US assignees by granted-patent volume, with 152 patents across 12 technology areas.
- #2,564
- of 49,997 US assignees by volume
- Top 15%
- by Innovation Score (49.3/100)
- 24.2
- avg claims per patent
- -28%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2564 · US Corporation #2,564 · 152 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MID 152 grants
- TOP-DECILE #2,564/49,997
- PHOTO-FINISH MannKind
- CPC-FOCUS A61N · 12 areas
- INNOV-PAR 49.3/100
- CLAIMS-DENSE 24.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -28% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: MannKind Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nevro’s 49.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nevro
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Woodwelding · near
Woodwelding · near
49 score
- Goertek Technology · near
Goertek Technology · near
49 score
- Idorsia Pharmaceutic… · near
Idorsia Pharmaceutic… · near
49 score
- Nevro · this assignee
Nevro · this assignee
49 score
- Nuscale Power · near
Nuscale Power · near
49 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nevro's Innovation Score is 49.3/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nevro?
Each dot is one of Nevro’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nevro’s own 24.2 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Nevro's grants concentrate
Nevro Corp. is a focused PatentsView assignee: 12 CPC subclasses with 96.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (27 grants) versus a trough of 9 in 2024. By volume, Nevro sits between Mitsui Kinzoku ACT Corporation and The Urban Electric Company.
Nevro's three-year grant acceleration
From 2019–2021 to 2022–2024, Nevro Corp. moved from 45 to 35 grants (0.78x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,901. See the growth leaderboard.
Who files at Nevro's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mitsui Kinzoku ACT
Mitsui Kinzoku ACT Corporation
152 patents
- Mannkind
MannKind Corporation
152 patents
- Merlin Technology
Merlin Technology Inc.
152 patents
- Nanotek Instrumen…
Nanotek Instruments Group, LLC
152 patents
- Peregrine Semicon…
Peregrine Semiconductor Corporation
152 patents
- Sofradim Producti…
Sofradim Production
152 patents
- Sennheiser & KG
Sennheiser electronic GmbH & Co. KG
152 patents
- The Urban Electric
The Urban Electric Company
152 patents
- Nevro ◀
Nevro Corp.
152 patents
What this shows Nevro holds 152 patents at rank #2,564, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nevro
By rank, the assignees closest to #2,564 in granted patent volume.
- Mitsui Kinzoku ACT Corporation #2,560 · 152 patents
- MannKind Corporation #2,561 · 152 patents
- Merlin Technology Inc. #2,562 · 152 patents
- Nanotek Instruments Group, LLC #2,563 · 152 patents
- Peregrine Semiconductor Corporation #2,565 · 152 patents
- Sofradim Production #2,566 · 152 patents
- Sennheiser electronic GmbH & Co. KG #2,567 · 152 patents
- The Urban Electric Company #2,568 · 152 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Nevro's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Nevro, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Nevro ranks #23 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (49 here).
Similar claim depth
Nearest assignees by average claims per patent (24.2 here).
Nevro's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 12 | 7.9% |
| 2016 | 27 | 17.8% |
| 2017 | 11 | 7.2% |
| 2018 | 11 | 7.2% |
| 2019 | 21 | 13.8% |
| 2020 | 11 | 7.2% |
| 2021 | 13 | 8.6% |
| 2022 | 13 | 8.6% |
| 2023 | 13 | 8.6% |
| 2024 | 9 | 5.9% |
| 2025partial year | 11 | 7.2% |
Which technologies does Nevro Corp. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Nevro Corp.'s patent record in context - here's where to go next.
- Nevro Corp.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 96.7% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #2,564 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Nevro Corp. against Mitsui Kinzoku ACT Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 49.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.